These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 20162567)

  • 21. Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer.
    Yang H; Kim C; Kim MJ; Schwendener RA; Alitalo K; Heston W; Kim I; Kim WJ; Koh GY
    Mol Cancer; 2011 Apr; 10():36. PubMed ID: 21481239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
    He Y; Kozaki K; Karpanen T; Koshikawa K; Yla-Herttuala S; Takahashi T; Alitalo K
    J Natl Cancer Inst; 2002 Jun; 94(11):819-25. PubMed ID: 12048269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
    Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
    Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis.
    Kopfstein L; Veikkola T; Djonov VG; Baeriswyl V; Schomber T; Strittmatter K; Stacker SA; Achen MG; Alitalo K; Christofori G
    Am J Pathol; 2007 Apr; 170(4):1348-61. PubMed ID: 17392173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial growth factor-D promotes growth, lymphangiogenesis and lymphatic metastasis in gallbladder cancer.
    Lin W; Jiang L; Chen Y; She F; Han S; Zhu J; Zhou L; Tang N; Wang X; Li X
    Cancer Lett; 2012 Jan; 314(2):127-36. PubMed ID: 22071224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis.
    Ochi N; Matsuo Y; Sawai H; Yasuda A; Takahashi H; Sato M; Funahashi H; Okada Y; Manabe T
    Pancreas; 2007 May; 34(4):444-51. PubMed ID: 17446844
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular endothelial growth factor (VEGF)-C, VEGF-D, VEGFR-3 and D2-40 expressions in primary breast cancer: Association with lymph node metastasis.
    Eroğlu A; Ersöz C; Karasoy D; Sak S
    Adv Clin Exp Med; 2017; 26(2):245-249. PubMed ID: 28791841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
    García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
    J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Curcumin inhibits lymphangiogenesis in vitro and in vivo.
    Wang W; Sukamtoh E; Xiao H; Zhang G
    Mol Nutr Food Res; 2015 Dec; 59(12):2345-54. PubMed ID: 26375757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SPARC suppresses lymph node metastasis by regulating the expression of VEGFs in ovarian carcinoma.
    Peng F; Zhong Y; Liu Y; Zhang Y; Xie Y; Lu Y; Zhang X; Li D
    Int J Oncol; 2017 Dec; 51(6):1920-1928. PubMed ID: 29075785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelin-1 cooperates with hypoxia to induce vascular-like structures through vascular endothelial growth factor-C, -D and -A in lymphatic endothelial cells.
    Garrafa E; Caprara V; Di Castro V; Rosanò L; Bagnato A; Spinella F
    Life Sci; 2012 Oct; 91(13-14):638-43. PubMed ID: 22552325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of vascular endothelial growth factor receptor-3 by lymphatic endothelial cells is associated with lymph node metastasis in prostate cancer.
    Zeng Y; Opeskin K; Baldwin ME; Horvath LG; Achen MG; Stacker SA; Sutherland RL; Williams ED
    Clin Cancer Res; 2004 Aug; 10(15):5137-44. PubMed ID: 15297417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New model of in-situ xenograft lymphangiogenesis by a human colonic adenocarcinoma cell line in nude mice.
    Sun JJ; Jing W; Ni YY; Yuan XJ; Zhou HH; Fan YZ
    Asian Pac J Cancer Prev; 2012; 13(6):2823-8. PubMed ID: 22938466
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fucoidan inhibits lymphangiogenesis by downregulating the expression of VEGFR3 and PROX1 in human lymphatic endothelial cells.
    Yang Y; Gao Z; Ma Y; Teng H; Liu Z; Wei H; Lu Y; Cheng X; Hou L; Zou X
    Oncotarget; 2016 Jun; 7(25):38025-38035. PubMed ID: 27203545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The relationship between lymphangiogenesis and lymphatic metastasis in murine hepatic carcinoma of high and low metastatic potentialities].
    Wang KF; Ye SL; Song LJ; Weng YQ; Liang CM; Zhao Y; Gao DM; Tang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):187-91. PubMed ID: 16556412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vascular endothelial growth factor (VEGF)-D in association with VEGF receptor-3 in lymphatic metastasis of breast cancer].
    Chen YN; Gu Y
    Ai Zheng; 2009 Dec; 28(12):1337-43. PubMed ID: 19958632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VEGF-D-induced draining lymphatic enlargement and tumor lymphangiogenesis promote lymph node metastasis in a xenograft model of ovarian carcinoma.
    Du LC; Chen XC; Wang D; Wen YJ; Wang CT; Wang XM; Kan B; Wei YQ; Zhao X
    Reprod Biol Endocrinol; 2014 Feb; 12():14. PubMed ID: 24502459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-tumor and anti-metastatic actions of wogonin isolated from Scutellaria baicalensis roots through anti-lymphangiogenesis.
    Kimura Y; Sumiyoshi M
    Phytomedicine; 2013 Feb; 20(3-4):328-36. PubMed ID: 23219337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.